Marijuana use and testicular germ cell tumors

Cancer

Volumn 117, Issue 4, 2011, Pages 848-853

  Trabert, Britton ^a   Sigurdson, Alice J ^a   Sweeney, Anne M ^b   Strom, Sara S ^c   Mcglynn, Katherine A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

hospital based case control; marijuana use; nonseminomas; seminomas; testicular germ cell tumors

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANNABIS SMOKING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TESTIS NONSEMINOMA CANCER; ALCOHOL CONSUMPTION; CANNABIS USE; CAUCASIAN; CRYPTORCHISM; HISPANIC; HISTOLOGY; RETROSPECTIVE STUDY; SEMINOMA; SMOKING; UNITED STATES;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; RISK FACTORS; TESTICULAR NEOPLASMS;

EID: 79551714520     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25499     Document Type: Article

References (26)

1. Curado MP, Edwards BK, Shin HR, et al. Cancer Incidence in Five Continents. Vol IX. IARC Scientific Publications No. 160. Lyon, France: IARC; 2007.
2. Horner M, Reis L, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. National Cancer Institute. Bethesda, MD. Available at:. Accessed January 2010.
3. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA., International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev. 2010; 19: 1151-1159.
4. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE., Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003; 97: 63-70.
5. Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H., Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol. 2006; 3: 532-543.
6. Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H., Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer. 2006; 118: 3099-3111.
7. Garner MJ, Turner MC, Ghadirian P, Krewski D., Epidemiology of testicular cancer: an overview. Int J Cancer. 2005; 116: 331-339.
8. Rajpert-De ME, Skakkebaek NE., The possible role of sex hormones in the development of testicular cancer. Eur Urol. 1993; 23: 54-59.
9. Skakkebaek NE, Rajpert-De ME, Jorgensen N, et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection ? APMIS. 1998; 106: 3-11.
10. Daling JR, Doody DR, Sun X, et al. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer. 2009; 115: 1215-1223.
11. Harmon J, Aliapoulios MA., Gynecomastia in marihuana users. N Engl J Med. 1972; 287: 936.
12. Harmon JW, Aliapoulios MA., Marijuana-induced gynecomastia: clinical and laboratory experience. Surg Forum. 1974; 25: 423-425.
13. Kolodny RC, Masters WH, Kolodner RM, Toro G., Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med. 1974; 290: 872-874.
14. Sigurdson AJ, Chang S, Annegers JF, et al. A case-control study of diet and testicular carcinoma. Nutr Cancer. 1999; 34: 20-26.
15. Sonke GS, Chang S, Strom SS, Sweeney AM, Annegers JF, Sigurdson AJ., Prenatal and perinatal risk factors and testicular cancer: a hospital-based case-control study. Oncol Res. 2007; 16: 383-387.
16. Walcott FL, Hauptmann M, Duphorne CM, Pillow PC, Strom SS, Sigurdson AJ., A case-control study of dietary phytoestrogens and testicular cancer risk. Nutr Cancer. 2002; 44: 44-51.
17. Richiardi L, Pettersson A, Akre O., Genetic and environmental risk factors for testicular cancer. Int J Androl. 2007; 30: 230-240. (Pubitemid 47254401)
18. Mandal TK, Das NS., Testicular toxicity in cannabis extract treated mice: association with oxidative stress and role of antioxidant enzyme systems. Toxicol Ind Health. 2010; 26: 11-23.
19. Wang H, Dey SK, Maccarrone M., Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev. 2006; 27: 427-448.
20. Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC., Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988; 34: 605-613.
21. Matsuda LA, Bonner TI, Lolait SJ., Cannabinoid receptors: which cells, where, how, and why? NIDA Res Monogr. 1992; 126: 48-56.
22. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI., Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990; 346: 561-564.
23. Munro S, Thomas KL, Abu-Shaar M., Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993; 365: 61-65.
24. Wenger T, Ledent C, Csernus V, Gerendai I., The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem Biophys Res Commun. 2001; 284: 363-368.
25. Gorzalka BB, Hill MN, Chang SC., Male-female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function. Horm Behav. 2010; 58: 91-99.
26. Liddell FD,. Simple exact analysis of the standardised mortality ratio. J Epidemiol Community Health. 1984; 38: 85-88.